Barbarroja, NuriaArias-de la Rosa, IvanLopez-Medina, ClementinaCamacho-Sanchez, Maria Del RosarioGomez-Garcia, IgnacioVelez Garcia-Nieto, AntonioEscudero-Contreras, AlejandroLopez-Pedrera, CharyLopez-Montilla, Maria DoloresCollantes-Estevez, Eduardo2023-02-082023-02-082019-10-16Barbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, et al. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X198807421759-720Xhttp://hdl.handle.net/10668/15522Cardiovascular disease (CVD) is the main cause of mortality in patients with psoriatic disease. Traditional cardiovascular (CV) risk factors, such as arterial hypertension (HTA), type 2 diabetes (T2D), and dyslipidaemia are more prevalent in these patients compared with the general population.1 Besides, the chronic inflammatory state induced by psoriatic disease contributes to subclinical atherosclerosis, making it possible to consider psoriatic disease as an independent CV risk factor.2 In fact, accelerated atherosclerosis has been associated with both psoriasis and psoriatic arthritis (PsA), progression of which is responsible for the majority of CVD mortality in these patientsenAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/Arthritis, psoriaticCardiovascular diseasesDiabetes mellitus, type 2Technology assessment, biomedicalPsoriasisRisk factorsHypertensionInflammationAtherosclerosisDyslipidemiasresearch article31662800open accessAterosclerosisDislipidemiasFactores de fiesgoHipertensiónInflamación10.1177/1759720X19880742PMC6796210https://journals.sagepub.com/doi/pdf/10.1177/1759720X19880742https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796210/pdf